Brand situation

Ergomar, owned by TerSera Therapeutics, is a treatment for migraine and cluster headaches. It has been on the market for a long time, but not readily available. First-line treatment for most migraines is a triptan. There are a variety of triptans available and doctors will try several to see what works for individual patients. Ergomar is a sublingual ergotamine and is the only sublingual treatment available in the US.

Project objective

Create a campaign to reintroduce Ergomar to headache treaters and highlight its sublingual administration.

Sales aid/Direct mailer

Outcome

Prescriptions have doubled in less than a year of launching the campaign.